Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Eur J Pharmacol
2009 Aug 15;6161-3:48-57. doi: 10.1016/j.ejphar.2009.06.023.
Show Gene links
Show Anatomy links
Two allelic isoforms of the serotonin transporter from Schistosoma mansoni display electrogenic transport and high selectivity for serotonin.
Fontana AC
,
Sonders MS
,
Pereira-Junior OS
,
Knight M
,
Javitch JA
,
Rodrigues V
,
Amara SG
,
Mortensen OV
.
???displayArticle.abstract???
The human blood fluke Schistosoma mansoni is the primary cause of schistosomiasis, a debilitating disease that affects 200 million individuals in over 70 countries. The biogenic amine serotonin is essential for the survival of the parasite and serotonergic proteins are potential novel drug targets for treating schistosomiasis. Here we characterize two novel serotonin transporter gene transcripts, SmSERT-A and SmSERT-B, from S.mansoni. Southern blot analysis shows that the two mRNAs are the products of different alleles of a single SmSERT gene locus. The two SmSERT forms differ in three amino acid positions near the N-terminus of the protein. Both SmSERTs are expressed in the adult form and in the sporocyst form (infected snails) of the parasite, but are absent from all other stages of the parasite's complex life cycle. Heterologous expression of the two cDNAs in mammalian cells resulted in saturable, sodium-dependent serotonin transport activity with an apparent affinity for serotonin comparable to that of the human serotonin transporter. Although the two SmSERTs are pharmacologically indistinguishable from each other, efflux experiments reveal notably higher substrate selectivity for serotonin compared with their mammalian counterparts. Several well-established substrates for human SERT including (+/-)MDMA, S-(+)amphetamine, RU 24969, and m-CPP are not transported by SmSERTs, underscoring the higher selectivity of the schistosomal isoforms. Voltage-clamp recordings of SmSERT substrate-elicited currents confirm the substrate selectivity observed in efflux experiments and suggest that it may be possible to exploit the electrogenic nature of SmSERT to screen for compounds that target the parasite in vivo.
Abidi,
From chlorpromazine to clozapine--antipsychotic adverse effects and the clinician's dilemma.
2003, Pubmed
Abidi,
From chlorpromazine to clozapine--antipsychotic adverse effects and the clinician's dilemma.
2003,
Pubmed
Barker,
Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.
1996,
Pubmed
Barker,
High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol.
1998,
Pubmed
Beckman,
Substrates and temperature differentiate ion flux from serotonin flux in a serotonin transporter.
2001,
Pubmed
,
Xenbase
Bennett,
Uptake of 5-hydroxytryptamine by Schistosoma mansoni.
1973,
Pubmed
Boyle,
Pharmacological and autoradiographical characterization of serotonin transporter-like activity in sporocysts of the human blood fluke, Schistosoma mansoni.
2003,
Pubmed
Boyle,
Serotonin-induced muscular activity in Schistosoma mansoni larval stages: importance of 5-HT transport and role in daughter sporocyst production.
2005,
Pubmed
Boyle,
Schistosoma mansoni: effects of serotonin and serotonin receptor antagonists on motility and length of primary sporocysts in vitro.
2000,
Pubmed
Daniels,
Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters.
1999,
Pubmed
Doenhoff,
Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance.
2006,
Pubmed
Domino,
History of modern psychopharmacology: a personal view with an emphasis on antidepressants.
1999,
Pubmed
Fairman,
Arachidonic acid elicits a substrate-gated proton current associated with the glutamate transporter EAAT4.
1998,
Pubmed
,
Xenbase
Gryseels,
Human schistosomiasis.
2006,
Pubmed
Gustafsson,
Immunocytochemical demonstration of neuropeptides and serotonin in the nervous systems of adult Schistosoma mansoni.
1987,
Pubmed
Hamdan,
Characterization of a stable form of tryptophan hydroxylase from the human parasite Schistosoma mansoni.
1999,
Pubmed
Harrop,
Protein synthesis and release by cultured schistosomula of Schistosoma mansoni.
1993,
Pubmed
Henry,
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.
2006,
Pubmed
Ingram,
Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons.
2002,
Pubmed
Khoshbouei,
N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux.
2004,
Pubmed
Larsen,
The chicken serotonin transporter discriminates between serotonin-selective reuptake inhibitors. A species-scanning mutagenesis study.
2004,
Pubmed
Mager,
Conducting states of a mammalian serotonin transporter.
1994,
Pubmed
,
Xenbase
Mansour,
Serotonin receptors in parasitic worms.
1984,
Pubmed
Mortensen,
Dynamic regulation of the dopamine transporter.
2003,
Pubmed
Mortensen,
Molecular cloning, expression and characterization of a bovine serotonin transporter.
1999,
Pubmed
Mortensen,
Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants.
2001,
Pubmed
Obenauer,
Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs.
2003,
Pubmed
Patocka,
Characterization of a serotonin transporter in the parasitic flatworm, Schistosoma mansoni: cloning, expression and functional analysis.
2007,
Pubmed
Pax,
Neuromuscular physiology and pharmacology of parasitic flatworms.
1996,
Pubmed
Rahman,
Schistosoma mansoni: effects of in vitro serotonin (5-HT) on aerobic and anaerobic carbohydrate metabolism.
1985,
Pubmed
Ranganathan,
Mutations in the Caenorhabditis elegans serotonin reuptake transporter MOD-5 reveal serotonin-dependent and -independent activities of fluoxetine.
2001,
Pubmed
Ribeiro,
Classical transmitters and their receptors in flatworms.
2005,
Pubmed
Rodríguez,
Distinct recognition of substrates by the human and Drosophila serotonin transporters.
2003,
Pubmed
Ross,
Schistosomiasis.
2002,
Pubmed
Sandhu,
A cocaine insensitive chimeric insect serotonin transporter reveals domains critical for cocaine interaction.
2002,
Pubmed
Schmid,
Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells.
2001,
Pubmed
Skelly,
Cloning, characterization, and functional expression of cDNAs encoding glucose transporter proteins from the human parasite Schistosoma mansoni.
1994,
Pubmed
,
Xenbase
Skelly,
Making sense of the schistosome surface.
2006,
Pubmed
Sonders,
Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants.
1997,
Pubmed
,
Xenbase
Steiner,
Going with the flow: trafficking-dependent and -independent regulation of serotonin transport.
2008,
Pubmed
Sung,
Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins.
2005,
Pubmed
Thompson,
Prospects for rational approaches to anthelmintic discovery.
1996,
Pubmed
Torres,
Plasma membrane monoamine transporters: structure, regulation and function.
2003,
Pubmed
Verjovski-Almeida,
Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni.
2003,
Pubmed
White,
Serotonin transporters: implications for antidepressant drug development.
2005,
Pubmed
Winnepenninckx,
Extraction of high molecular weight DNA from molluscs.
1993,
Pubmed
Wood,
Schistosoma mansoni: serotonin uptake and its drug inhibition.
1986,
Pubmed
